XLS

Xlife Sciences AG

Stock SIX Swiss Exchange – Stock Market Prices, News & Analysis

Xlife Sciences AG is a Swiss company specializing in the research, development, and commercialization of natural health products, including dietary supplements and nutraceuticals.

Fr. 21.10
1.40 %

Xlife Sciences AG

Fr. 21.10
1.40 %
XLS

Xlife Sciences AG is a Swiss company specializing in the research, development, and commercialization of natural health products, including dietary supplements and nutraceuticals.

Price history of Xlife Sciences AG
Price history of Xlife Sciences AG

Performance & Momentum

6 Months
1 Year 21.92 %
3 Years 36.16 %
5 Years 60.96 %

Strategic Analysis

Xlife Sciences AG • 2026

Xlife Sciences AG positions itself as a niche player in the healthcare sector by combining medical research with the development of innovative natural products, notably in dietary supplements and nutraceuticals. Its differentiation rests on a strong integration between scientific research and the targeted commercialization of natural health solutions.

Strengths
  • Advanced expertise in high-value-added natural health products
  • Diversified offering including innovative dietary supplements and nutraceuticals
  • European footprint with expertise in medical R&D
Weaknesses
  • Historical financial performance marked by significant volatility
  • Exposure to strict regulations governing natural health products
Momentum

Current momentum is moderate, and the stock has shown a recent positive trend despite a significant decline over the medium and long term. This suggests an early turnaround or renewed interest, warranting caution regarding the strength of ongoing projects and the company’s ability to stabilize growth.

Similar stocks to Xlife Sciences AG

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone